WAVE Life Sciences (WVE) Misses Q1 EPS by 3c

WAVE Life Sciences (NASDAQ: WVE) reported Q1 EPS of ($0.24), $0.03 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $12.54 million versus the consensus estimate of $25 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Five Below (FIVE) Tops Q2 EPS by 35c, Beats on Revenue; Offers Q3 Revenue Guidance
• Phreesia Inc. (PHR) Misses Q2 EPS by 6c; Offers Guidance